Gene therapy for spinal muscular atrophy with onasemnogene abeparvovec. Statement of the German Speaking Society of Neuropediatrics

Kirschner, Janbernd; Bernert, Günther; v. der Hagen, Maja; Hahn, Andreas; Johannsen, Jessika; Klein, Andrea; Müller-Felber, Wolfgang; Ziegler, Andreas; Schara, Ulrike (2020). Gene therapy for spinal muscular atrophy with onasemnogene abeparvovec. Statement of the German Speaking Society of Neuropediatrics. Monatsschrift Kinderheilkunde, 168(10), pp. 938-941. Springer-Verlag 10.1007/s00112-020-00944-6

[img] Text
2018_Article_.pdf - Published Version
Restricted to registered users only until 6 June 2024.
Available under License Publisher holds Copyright.

Download (320kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Neuropaediatrics
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine

UniBE Contributor:

Klein, Andrea Katharina

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0026-9298

Publisher:

Springer-Verlag

Language:

German

Submitter:

Anette van Dorland

Date Deposited:

27 Jan 2021 10:22

Last Modified:

05 Dec 2022 15:43

Publisher DOI:

10.1007/s00112-020-00944-6

BORIS DOI:

10.48350/150627

URI:

https://boris.unibe.ch/id/eprint/150627

Actions (login required)

Edit item Edit item
Provide Feedback